Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative clonidine for sleep disturbance and delirium prevention
ACTRN12619000669190Phase 3Terminated
- Sponsor
- The University of Queensland
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clonidine, sponsored by The University of Queensland. Started May 2019; status: terminated.
02
Drugs
clonidine
Beyond the preview
Go deeper on ACTRN12619000669190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000669190.